Kemia, Inc. Closes Series C Financing
Published: Aug 23, 2006
SAN DIEGO--(BUSINESS WIRE)--Aug. 23, 2006--Kemia announced today that it has closed its Series C financing, raising $31 million from new and existing investors. The company plans to use the proceeds to advance its lead clinical compound, KC706, through initial Phase II clinical trials and to progress additional Kemia programs into the clinic.